DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162899

Osteocalcin: an emerging biomarker for bone turnover

Brijesh Rathore, Manisha Singh, Vishnu Kumar, Aparna Misra

Abstract


Osteocalcin (OC) is produced by osteoblasts during bone formation. OC is excreted into urine by glomerular filtration and can be found as fragments in urine. The presence of three vitamin K-dependent γ-carboxyglutamic acid residues is critical for osteocalcin’s structure, which appears to regulate the maturation of bone mineral. Recent bone biology research have highlighted the importance of bone not only as a structural scaffold to support the human body, but also as a regulator of a metabolic processes that are independent of mineral metabolism. Circulating osteocalcin is present either as carboxylated or as undercarboxylated forms. Increased serum level of osteocalcin is linked with increased bone mineral density. The importance of the bone–kidney relation in physiologic regulation of mineral ion has also been extensively studied and documented.  Several workers have uncovered the role of insulin as an additional factor involved in the skeletal remodelling process. Evidences are available which shows that osteoblastic insulin signalling is important for glucose metabolism. The measurement of OC in urine samples could be used as an index of bone turnover in monitoring bone metabolism. In this review, we have tried to explain different roles of OC, however further studies are required to elucidate the metabolic and hormonal role of OC in human body.


Keywords


Osteocalcin, Urinary Osteocalcin, Bone turn over, Bone resorption

Full Text:

PDF

References


Pino JD, Gomez EM, Rodriguez MM, Sosa CL, Cordero M, Lanchares JL, et al. Influence of sex, age and menopause in serum osteocalcin (BGP) levels. J Mol Med. 1991;69(24):1135-8.

Allison JL, Stephen H, Richard E. Measurement of osteocalcin. Ann Clin Biochem. 2000;37:432-46.

Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med. 2009;218:201-5.

Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem. 2004;279:18361-9.

Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA. 1974;71:2730-3.

Hauschka PV, Reid ML. Timed appearance of a calcium-binding protein containing gamma-carboxyglutamic acid in developing chick bone. Dev Biol. 1978;65:426-34.

Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA. 1976;73:1447-51.

Dowd TL, Rosen JF, Li L, Gundberg CM. The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry. 2003;42:7769-79.

Hauschka PV, Carr SA. Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry. 1982;21:2538-47.

Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagama Y, et al. and Jpos Study Group. Reference database of biochemical markers of bone turnover for the Japanese female population. Osteoporos. Int. 2004;15:981-91.

Ingram RT, Park YK, Clarke BL, Fitzpatrick LA. Age and gender related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodelling. J Clin Invest. 1994;93:989-97.

Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res. 1992;7:1389-98.

Taylor AK, Linkhart S, Mohan S, Christenson RA, Singer FR, Baylink DJ. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay. J Clin Endocrinol Metab. 1990;70:467-72.

Cairns JR, Price PA. Direct demonstration that the vitamin K-dependent bone Gla protein is incompletely gamma-carboxylated in humans. J Bone Miner Res. 1994;9:1989-97.

Price PA, Williamson MK. Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone. J Biol Chem. 1981;256:12754-9.

Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent protein found in plasma and its clearance by kidney and bone. J. Biol. Chem. 1981;256:12760-6.

Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in eldery women: the EPIDOS study. J Clin Endocrinol Metab 1997;82:719-24.

Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr. 2003;77:512-6.

Booth SL. Roles for vitamin K beyond coagulation. Annu Rev Nutr. 2009;29:89-110.

Knapen MH, Nieuwenhuijzen-Kruseman AC, Wouters RSME, Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int. 1998;63:375-9.

Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab. 2004;89:4904-9.

Braam L, McKeown N, Jacques P, Lichtenstein A, Vermeer C, Wilson P, et al. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. J Am Diet Assoc. 2004;104:1410-4.

Erkkilä AT, Booth SL, Hu FB, Jacques PF, Manson JE, Rexrode KM, et al. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur J Clin Nutr. 2005;59:196-204.

Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-69.

Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev. 1989;69: 990-1047.

Hauschka PV, Wians FH Jr. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec. 1989;224:180-8.

Delmas PD. Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos Int. 1993;3(Suppl 1):81-6.

Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-69.

Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodelling and energy metabolism. Cell. 2010;142:296-308.

Kumm J, Ivaska KK, Rohtla K, Vaananen K, Tamm A. Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. Scand J Clin Lab Invest. 2008;68:459-63.

Khosla S, Atkinson EJ, Riggs BL, Melton LJ III. Relationship between body composition and bone mass in women. J Bone Miner Res. 1996;11:857-63.

Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab. 2007;92:1640-6.

Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res. 1999;14:1622-7.

Prats-Puig A, Mas-Parareda M, Riera-Perez E, Gonzalez-Forcadell D, Mier C, Mallol-Guisset M, et al. Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care. 2010;33:661-3.

Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827-32.

Fernández-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gomez-Ambrosi J, Moreno-Navarrete JM, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab. 2009;94:237-45.

Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009;90: 1230-5.

Beulens JW, van der A DL, Grobbee DE, Sluijs I, Spijkerman AM, van der Schouw YT. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care. 2010;33:1699-705.

Gundberg C. Osteocalcin. In: Eastell R, Baumann M, Hoyle NR, Wieczorek L, eds. Bone markers: biochemical and clinical perspectives. London: Martin Dunitz Ltd., 2001;65-72.

Gundberg CM, Weinstein RS. Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest. 1986;77:1762-7.

Farrugia W, Melick RA. Metabolism of osteocalcin. Calcif Tissue Int. 1986;39:234-8.

Ivaska KK, Hentunen TA, Va¨a¨ra¨niemi J, Ylipahkala H, Pettersson K, Va¨a¨na¨nen HK. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem. 2004;279:18361-9.

Civitelli R, Armamento- Villareal R, Napoli N. Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporosis Int. 2009;20:853-61.

Banfi G, Daverio R. In vitro stability of osteocalcin. Clin Chem. 1994;40:833-4.

Malluche HM, M. C. Faugere, P. Fanti, and P. A. Price. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int. 1984;26:869-74.

Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2000;11(Suppl 6):S30-44.